Literature DB >> 10842162

Chronic ergot toxicity: A rare cause of lower extremity ischemia.

G D Garcia1, J M Goff, N C Hadro, S D O'donnell, P S Greatorex.   

Abstract

Chronic ergot toxicity is a rare cause of lower extremity ischemia. The cornerstone of therapy in ergot toxicity is to discontinue the use of caffeine, cigarettes, and all ergot-containing medications. Although multiple different therapies have been recommended for acute toxicity, no specific treatment is uniformly recommended in chronic toxicity. We present a case of long-term ergot use for migraine headaches in a woman who had severe chronic lower extremity claudication. This case demonstrates the unique features associated with the diagnosis and management of chronic ergot toxicity. We recommend a conservative approach consisting of observation, antiplatelet agents, and the discontinuance of ergots. If symptoms progress to rest pain or gangrene, surgical treatment should be considered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10842162     DOI: 10.1067/mva.2000.105668

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Ergotamine-induced upper extremity ischemia: a case report.

Authors:  Man Deuk Kim; Gun Lee; Sung Wook Shin
Journal:  Korean J Radiol       Date:  2005 Apr-Jun       Impact factor: 3.500

2.  Ergotism with ischemia in all four extremities: a case report.

Authors:  Seok-Young Jeong; Eui-Seong Lim; Byoung-Soo Shin; Man-Wook Seo; Young-Hyun Kim; Hyo-Sung Kwak; Gyung-Ho Chung; Seul-Ki Jeong
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

3.  Ergotism: Case Report and Review of the Literature.

Authors:  Claudia A Liegl; Michael A McGrath
Journal:  Int J Angiol       Date:  2015-02-09

4.  Digital ischemia associated with cancer: results from a cohort study.

Authors:  Maëlle Le Besnerais; Sébastien Miranda; Nicole Cailleux; Nicolas Girszyn; Isabelle Marie; Hervé Lévesque; Ygal Benhamou
Journal:  Medicine (Baltimore)       Date:  2014-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.